AB-95-LH34_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, Benzamide, N-[3-[6-amino-5-[[1-(1-oxo-2-propen-1-yl)-3-azetidinyl]oxy]-4-pyrimidinyl]-5-fluoro-2-methylphenyl]-4-cyclopropyl-2-fluoro-, irreversible, covalent inhibitor of BTK;Btk tyrosine kinase inhibitor targeting BTK (Novartis, 118107484)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/118107484
Similar Terms
Downloads & Tools

Genes

11 genes differentially expressed following the AB-95-LH34_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
THOC6 THO complex 6 1.33818
MYL2 myosin, light chain 2, regulatory, cardiac, slow 0.526457
NDUFAF8 NADH:ubiquinone oxidoreductase complex assembly factor 8 0.440626
GSTP1 glutathione S-transferase pi 1 0.436233
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.390691
C19ORF33 chromosome 19 open reading frame 33 0.335656
RPL31 ribosomal protein L31 0.278257
TCEAL7 transcription elongation factor A (SII)-like 7 0.261421
ROMO1 reactive oxygen species modulator 1 0.234841
S100A2 S100 calcium binding protein A2 0.202441

decreased expression

Symbol Name Standardized Value
TPR translocated promoter region, nuclear basket protein -0.261421